Emorfazone
Emorfazone (Pentoil) is a non-steroidal anti-inflammatory drug with oral activity. Emorfazone can significantly inhibit the release of bradykinin-like substances and kininogen. Emorfazone has anti-inflammatory and analgesic activity[1].
Product Specifications
CAS Number
[38957-41-4]
Product Name Alternative
Pentoil; Nandron
UNSPSC
12352005
Hazard Statement
H302
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/emorfazone.html
Solubility
10 mM in DMSO
Smiles
O=C1C(OCC)=C(N2CCOCC2)C=NN1C
Molecular Formula
C11H17N3O3
Molecular Weight
239.27
Precautions
P264-P270-P330-P501
References & Citations
[1]Sato M, et al. Studies on mechanisms of action of emorfazone. Effects on the release of bradykinin-like substance in thermic edema of rat paws. Arzneimittelforschung. 1982;32 (4) :379-82.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15366633 1 Vial
Lentiviral human YWHAE sgRNA gene knockout kit - Lentiviral human YWHAE sgRNA gene knockout kit (25)
Ask
View Details 
MBS6377423-01 0.1 mL
ENTPD3 (Ectonucleoside Triphosphate Diphosphohydrolase 3, NTPDase 3, CD39 Antigen-like 3, Ecto-ATP Diphosphohydrolase 3, Ecto-ATPDase 3, Ecto-ATPase 3, Ecto-apyrase 3, HB6, CD39L3) (MaxLight 650)
Ask
View Details 
MBS6377423-02 5x 0.1 mL
ENTPD3 (Ectonucleoside Triphosphate Diphosphohydrolase 3, NTPDase 3, CD39 Antigen-like 3, Ecto-ATP Diphosphohydrolase 3, Ecto-ATPDase 3, Ecto-ATPase 3, Ecto-apyrase 3, HB6, CD39L3) (MaxLight 650)
Ask
View Details